Diligence memo · auto-generated · as of July 2, 2026

PreciseDx, Inc.

PreciseDx, Inc. looks under-valued against its niche peers and is active on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

PreciseDx, Inc. operates in Other Health Care, based in NEW YORK.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

PreciseDx, Inc. has raised $32M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $21M on 2024-02-20.

Most recent recorded round closed around 2025-05-28.

Valuation (modeled)modeled

Provath models PreciseDx, Inc. at approximately $56M (range $26M–$84M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.60× the median modeled value of Series B Other Health Care companies in 2025–2027 (48 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 8 months.

Last raise 13 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

The last round was 1.8× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 89% of Other Health Care peers (5377 compared).

Modeled value ranks above 69% of those peers.

Closest niche peers: Imagine Pediatrics Holdings LLC, Porter Cares, Inc., True Medicine Inc., CranioVation, Inc., Seriously Clean LTD..

Peoplefiled

8 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.